Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug 15;2(8):180-4.
doi: 10.1097/WOX.0b013e3181b2ff8a.

Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis

Michael A Kaliner  1 , James N Baraniuk, Michael S Benninger, Jonathan A Bernstein, Phil Lieberman, Eli O Meltzer, Robert M Naclerio, Russell A Settipane, Judith R Farrar
Affiliations

Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis

Michael A Kaliner et al. World Allergy Organ J. .

Abstract

"Nonallergic rhinopathy" was defined by consensus at a Roundtable conference in December 2008 as "a chronic nasal condition with symptoms that may be perennial, persistent, intermittent or seasonal and/or elicited by recognized triggers." The definition includes a well-recognized set of clinical exposures that lead to the symptoms, predominantly congestion, rhinorrhea, and postnasal drip. These clinical characteristics help to identify patients for participation in clinical trials examining the efficacy of treatments for this important disease. The next step is to establish inclusion and exclusion criteria that will provide a framework for the clinical trials. Agreement on study criteria was obtained at the consensus conference by discussion, counterpoint, and compromise.

PubMed Disclaimer

References

    1. Brandt D, Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic rhinitis. Annals Allergy Asthma Immunol. 2006;2:526–531. doi: 10.1016/S1081-1206(10)63546-6. - DOI - PubMed
    1. Dykewicz M, Fineman S, editor. Ann Allergy Asthma Immunol. Vol. 2. 1998. Diagnosis and management of rhinitis: complete guidelines of the joint task force on practice parameters in allergy, asthma, and immunology; pp. 478–518. - DOI - PubMed
    1. Fokkens WJ. Thoughts on pathophysiology of nonallergic rhinitis. Curr Allergy Asthma Rep. 2002;2:203–209. doi: 10.1007/s11882-002-0020-3. - DOI - PMC - PubMed
    1. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol. 2001;2:494–507. doi: 10.1016/S1081-1206(10)62896-7. - DOI - PubMed
    1. Wallace DV, Dykewicz M. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;2:S1–S84. doi: 10.1016/j.jaci.2008.06.003. - DOI - PubMed